Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
暂无分享,去创建一个
Geneviève Milon | G. Milon | T. Lang | Nathalie Courret | Thierry Lang | Jean Claude Antoine | N. Courret | J. Antoine
[1] R. Locksley,et al. The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.
[2] T. Curiel,et al. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. , 1998, Journal of immunology.
[3] Y. Belkaid,et al. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. , 2000, Science.
[4] J. Blackwell,et al. IL-13 Is a Susceptibility Factor for Leishmania major Infection , 2000, The Journal of Immunology.
[5] Y. Belkaid,et al. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. , 1996, Journal of immunology.
[6] D. Sacks,et al. Metacyclogenesis in Leishmania promastigotes. , 1989, Experimental parasitology.
[7] C. Fréhel,et al. Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages , 2001, Parasitology.
[8] M. Lohoff,et al. Polyclonal B-cell stimulation by L3T4+ T cells in experimental leishmaniasis , 1988, Infection and immunity.
[9] H. Bielefeldt-Ohmann,et al. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.
[10] Hai Qi,et al. Leishmania amazonensis-Dendritic Cell Interactions In Vitro and the Priming of Parasite-Specific CD4+ T Cells In Vivo1 , 2001, The Journal of Immunology.
[11] G. Milon,et al. The Levels and Patterns of Cytokines Produced by CD4 T Lymphocytes of BALB/c Mice Infected with Leishmania major by Inoculation into the Ear Dermis Depend on the Infectiousness and Size of the Inoculum , 2003, Infection and Immunity.
[12] Douglas E. Jones,et al. Early Enhanced Th1 Response after Leishmania amazonensis Infection of C57BL/6 Interleukin-10-Deficient Mice Does Not Lead to Resolution of Infection , 2002, Infection and Immunity.
[13] M. Röllinghoff,et al. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. , 1993, The Journal of infectious diseases.
[14] N. Glaichenhaus,et al. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites , 1999, European journal of immunology.
[15] C. Bogdan,et al. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major , 1994, The Journal of experimental medicine.
[16] M. Meltzer,et al. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. , 1988, Journal of immunology.
[17] R. Locksley,et al. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.
[18] R. Rerko,et al. Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.
[19] R. Locksley,et al. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[20] P. Scott,et al. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis , 1993, Infection and immunity.
[21] P. Bretscher,et al. Immune Elimination of Leishmania major in Mice: Implications for Immune Memory, Vaccination, and Reactivation Disease1 , 2001, The Journal of Immunology.
[22] Y. Belkaid,et al. The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.
[23] C. Auriault,et al. IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. , 2002, Parasitology international.
[24] D. Biegel,et al. Leishmania mexicana: temperature sensitivity of isolated amastigotes and of amastigotes infecting macrophages in culture. , 1983, Experimental parasitology.
[25] Y. Belkaid,et al. Transient inducible events in different tissues: in situ studies in the context of the development and expression of the immune responses to intracellular pathogens. , 1994, Immunobiology.
[26] W A Buurman,et al. Limiting dilution assays. Experimental design and statistical analysis. , 1987, Journal of immunological methods.
[27] D. Sacks,et al. The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.
[28] C. Taswell,et al. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.
[29] P. Bretscher,et al. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite , 1998, European journal of immunology.
[30] É. Prina,et al. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. , 1998, Trends in microbiology.
[31] A. Sher,et al. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. , 1985, Journal of immunology.
[32] Douglas E. Jones,et al. IL-4-Independent Inhibition of IL-12 Responsiveness During Leishmania amazonensis Infection1 , 2000, The Journal of Immunology.
[33] M. Roncarolo,et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.
[34] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[35] J. Shaw,et al. Leishmaniasis in Brazil: I. Observations on enzootic rodent leishmaniasis--incrimination of Lutzomyia flaviscutellata (Mangabeira) as the vector in the Lower Amazonian Basin. , 1968, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[36] J. Sun,et al. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. , 1997, Journal of immunology.
[37] T. Aoki,et al. Inhibition of Fas-mediated apoptosis by Trypanosoma cruzi infection. , 2000, Biochimica et biophysica acta.
[38] T. Springer,et al. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. , 1981, Journal of immunology.
[39] P. Bretscher,et al. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge , 1996, European journal of immunology.
[40] J. Sun,et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. , 1996, Immunity.
[41] W. Paul,et al. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. , 1999, Journal of immunology.
[42] Y. Belkaid,et al. A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity , 2000, The Journal of Immunology.
[43] A. Ismail,et al. Necrotizing and suppurative lymphadenitis in Leishmania major infections , 1996, Tropical medicine & international health : TM & IH.
[44] Y. Schlein,et al. The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. , 1986, The American journal of tropical medicine and hygiene.
[45] R. L. Berens,et al. An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. , 1978, The Journal of parasitology.
[46] Doherty Tm,et al. Leishmania major:Effect of Infectious Dose on T Cell Subset Development in BALB/c Mice , 1996 .
[47] H. Karasuyama,et al. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.
[48] K. Moore,et al. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. , 1994, Journal of immunology.
[49] D. Sacks,et al. Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. , 1983, The American journal of tropical medicine and hygiene.
[50] F. Weinbaum,et al. Leishmania tropica: association of a B-cell mitogen with hypergammaglobulinemia in mice. , 1982, Experimental parasitology.
[51] D. Mosser,et al. The Role of IL-10 in Promoting Disease Progression in Leishmaniasis1 , 2001, The Journal of Immunology.
[52] A. Ryter,et al. Megasomes as the targets of leucine methyl ester in Leishmania amazonensis amastigotes , 1989, Parasitology.
[53] J. Shaw,et al. Leishmaniasis in Brazil. V. Studies on the epidemiology of cutaneous leishmaniasis in Mato Grosso State, and observations on two distinct strains of Leishmania isolated from man and forest animls. , 1970, Transactions of the Royal Society of Tropical Medicine and Hygiene.